Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Choosing the right budgeting method can transform your financial health. Explore the most effective options that suit your needs.
23,927 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Universal Corp misses EPS and swings to a loss in the third quarter, triggering a double-digit stock drop. Analysts f...
IonQ posted triple-digit revenue growth for 2025, reaching a new high, while losses intensified. The stock has fallen...
Oil prices cooled after news that wealthy nations may coordinate an emergency reserve release. Analysts warn that pri...
February CPI data matched expectations, keeping the Fed on track. The crypto market weighs how will bitcoin’s price r...
TMC jumped on regulatory news, but the road to deep-seabed mining remains lengthy and costly. This guide breaks down ...
As Costco’s sales momentum stays strong, investors wonder if the stock can keep delivering. This guide breaks down th...
As the Senate moves to vote on the ROAD to Housing Act, trade groups warn that key provisions could constrain housing...
Bitcoin steadies near the $70,000 mark as oil prices leap and geopolitical tensions rise. Analysts weigh whether the ...
Bumble reports softer user growth and a hefty impairment bill, even as cash flow improves. The AI-driven reboot is dr...
Investors are weighing Oklo's unique nuclear energy model against a bumpy ride in its stock. This guide breaks down t...
When a CEO disposes of stock, investors want context. This deep dive explains what fastly's sold company shares could...